Physician
Mercy Hospitals East Communities
Mercy Hospitals East Communities was paid $56.55M by Medicaid between Jan 2018 and Dec 2024, across 191 billing codes. Its largest line is Y7506, — 16% of everything it billed.
33Billing provider infoMERCY HOSPITALS EAST COMMUNITIES
SAINT LOUIS, MO 63141
SAINT LOUIS, MO 63141
33aNPI1427098169assigned 06/08/2006
33bProvider typeFamily Medicine Physician
28Total paid$56.55M
24GClaims476,120
24DCodes billed191
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Missouri
Rank by total paid#1 of 911
Median peer was paid$16K
This provider vs. median3,595×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 65,076 | $14.06M | |
| 2019 | 61,876 | $12.75M | |
| 2020 | 54,861 | $4.67M | |
| 2021 | 68,695 | $2.07M | |
| 2022 | 77,413 | $6.57M | |
| 2023 | 83,256 | $8.69M | |
| 2024incomplete | 64,943 | $7.75M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| Y7506 | 16% | 37,986 | 32,087 | $9.24M | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 53,063 | 42,674 | $9.06M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 45,032 | 35,922 | $6.65M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 42,349 | 33,768 | $5.73M |
| X4011 | State-specific procedure code | 6.6% | 19,040 | 18,025 | $3.75M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.9% | 54,809 | 44,469 | $2.23M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.8% | 25,009 | 22,582 | $1.58M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.6% | 7,469 | 6,684 | $1.46M |
| 80053 | Comprehensive metabolic panel | 2.5% | 43,162 | 35,689 | $1.42M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.9% | 3,687 | 3,632 | $1.06M |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.8% | 3,129 | 1,557 | $1.02M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 1.6% | 2,100 | 2,021 | $882K |
179 more codes
| 59025 | Fetal non-stress test | 1.6% | 4,483 | $879K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.3% | 1,357 | $739K |
| 55175 | 1.2% | 570 | $679K | |
| 93325 | 1.1% | 1,690 | $638K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,364 | $542K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 9,604 | $539K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12,369 | $526K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,577 | $452K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 3,163 | $436K |
| 93320 | <1% | 1,032 | $431K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 120 | $350K |
| 81002 | <1% | 7,139 | $306K | |
| 74018 | <1% | 2,673 | $253K | |
| X4003 | <1% | 4,285 | $243K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,451 | $242K |
| 54304 | <1% | 136 | $237K | |
| 76770 | <1% | 2,675 | $231K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,179 | $210K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 201 | $189K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 2,930 | $177K |
| 94060 | <1% | 1,185 | $177K | |
| 36591 | <1% | 3,366 | $175K | |
| 90686 | <1% | 4,247 | $172K | |
| 81001 | <1% | 3,438 | $171K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,695 | $167K |
| V2020 | Frames, purchases | <1% | 1,897 | $129K |
| 90698 | <1% | 2,221 | $117K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 836 | $108K |
| 90670 | <1% | 1,698 | $108K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,230 | $103K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,366 | $98K |
| 80061 | Lipid panel | <1% | 1,452 | $89K |
| D7999 | <1% | 662 | $89K | |
| 92567 | <1% | 1,762 | $87K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,556 | $84K |
| G0378 | Hospital observation service, per hour | <1% | 294 | $81K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 143 | $75K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 769 | $72K |
| 87070 | <1% | 707 | $70K | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 1,150 | $70K |
| J3490 | Unclassified drugs | <1% | 3,116 | $69K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,224 | $64K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 867 | $60K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 840 | $59K |
| 84450 | <1% | 1,067 | $58K | |
| 84460 | <1% | 1,064 | $57K | |
| 87631 | <1% | 176 | $56K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,495 | $55K |
| 84439 | <1% | 841 | $54K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 705 | $54K |
| 90744 | <1% | 993 | $54K | |
| 90633 | <1% | 1,089 | $53K | |
| 54161 | <1% | 25 | $51K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 628 | $48K |
| 90681 | <1% | 881 | $47K | |
| 81003 | <1% | 672 | $45K | |
| 90651 | <1% | 705 | $43K | |
| 83655 | <1% | 1,240 | $41K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 413 | $40K |
| 53605 | <1% | 54 | $37K | |
| 86140 | <1% | 425 | $37K | |
| 80081 | <1% | 491 | $35K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 232 | $33K |
| 85018 | <1% | 1,098 | $33K | |
| 85014 | <1% | 1,098 | $33K | |
| 94760 | <1% | 630 | $29K | |
| 96367 | <1% | 887 | $29K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 721 | $28K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 529 | $28K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 3,077 | $26K |
| 87807 | <1% | 85 | $22K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 344 | $21K |
| 87081 | <1% | 1,115 | $21K | |
| 92555 | <1% | 220 | $21K | |
| 94761 | <1% | 29 | $20K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 54 | $19K |
| 74019 | <1% | 228 | $18K | |
| 87481 | <1% | 87 | $18K | |
| 87511 | <1% | 71 | $18K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 168 | $17K |
| 90734 | <1% | 219 | $16K | |
| 83516 | <1% | 46 | $15K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 393 | $15K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 81 | $14K |
| 82397 | <1% | 141 | $14K | |
| 92587 | <1% | 215 | $13K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 89 | $11K |
| 0072A | <1% | 293 | $11K | |
| 94010 | <1% | 561 | $10K | |
| 82784 | <1% | 92 | $10K | |
| 87799 | <1% | 33 | $9K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 115 | $9K |
| X4006 | <1% | 14 | $9K | |
| G0381 | Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 98 | $9K |
| 92552 | <1% | 52 | $8K | |
| Y7507 | <1% | 119 | $8K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 46 | $7K |
| 82728 | <1% | 295 | $7K | |
| 95819 | <1% | 24 | $6K | |
| 92015 | Determination of refractive state | <1% | 851 | $6K |
| 15852 | <1% | 13 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 158 | $6K |
| 85610 | <1% | 53 | $6K | |
| 85652 | <1% | 50 | $6K | |
| 87088 | <1% | 164 | $6K | |
| 71045 | Radiologic examination, chest; single view | <1% | 115 | $6K |
| 0071A | <1% | 197 | $5K | |
| 90707 | <1% | 122 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 174 | $5K |
| 90716 | <1% | 127 | $4K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 17 | $4K |
| 86580 | <1% | 67 | $4K | |
| 87428 | <1% | 163 | $4K | |
| 84702 | <1% | 510 | $4K | |
| 81025 | <1% | 326 | $3K | |
| 92579 | <1% | 40 | $3K | |
| 90710 | <1% | 44 | $3K | |
| 0240U | <1% | 34 | $3K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 12 | $3K |
| 73120 | <1% | 52 | $3K | |
| 0052A | <1% | 95 | $3K | |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | <1% | 39 | $3K |
| 90715 | <1% | 36 | $3K | |
| 86803 | <1% | 44 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 31 | $3K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 28 | $3K |
| 54162 | <1% | 13 | $3K | |
| 92582 | <1% | 29 | $3K | |
| 90656 | <1% | 569 | $3K | |
| 74455 | <1% | 12 | $3K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 32 | $2K |
| 90677 | <1% | 427 | $2K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 17 | $2K |
| 0001A | <1% | 56 | $2K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 29 | $2K |
| 90620 | <1% | 29 | $2K | |
| 82950 | <1% | 70 | $2K | |
| 0002A | <1% | 54 | $2K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 54 | $2K |
| 84466 | <1% | 251 | $2K | |
| 86900 | <1% | 58 | $2K | |
| 96417 | <1% | 57 | $2K | |
| 82607 | <1% | 198 | $1K | |
| 95812 | <1% | 13 | $1K | |
| 83037 | <1% | 219 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 36 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 31 | $1K |
| 82746 | <1% | 180 | $1K | |
| 93308 | <1% | 23 | $950.74 | |
| 85027 | <1% | 28 | $927.66 | |
| 83540 | <1% | 251 | $869.65 | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 13 | $763.88 |
| 83615 | <1% | 252 | $722.38 | |
| 0124A | <1% | 35 | $680.00 | |
| 86901 | <1% | 58 | $529.66 | |
| 84484 | <1% | 43 | $457.02 | |
| 81513 | <1% | 48 | $456.40 | |
| 0003A | <1% | 19 | $440.00 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 139 | $373.10 |
| 87430 | <1% | 93 | $358.81 | |
| D1120 | Dental cleaning, child | <1% | 14 | $344.57 |
| 83880 | <1% | 13 | $333.52 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 44 | $331.32 |
| 82657 | <1% | 78 | $228.85 | |
| 84703 | <1% | 37 | $194.20 | |
| 90480 | <1% | 17 | $190.16 | |
| D1110 | Prophylaxis - adult | <1% | 33 | $168.08 |
| 90619 | <1% | 29 | $163.62 | |
| 54450 | <1% | 19 | $146.65 | |
| 83690 | <1% | 25 | $57.82 | |
| 87653 | <1% | 16 | $28.07 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 38 | $1.47 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 188 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 356 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 16 | $0.00 |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 0% | 14 | $0.00 |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 12 | $0.00 |
| 90662 | 0% | 44 | $0.00 | |
| 88302 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCOFFIC, DENISE (VICE PRESIDENT FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Mercy Hospitals East Communities | Saint Louis, MO | $2.59M |
| Mercy Health Services, LLC | Saint Louis, MO | $152K |
| Mercy Health Services LLC | Saint Louis, MO | $147K |
| Mercy Health Services LLC | Saint Louis, MO | $37K |
| Mercy Hospitals East Communities | Saint Louis, MO | $15K |
| Mercy Health Services, LLC | St. Louis, MO | $15K |
| Mercy Hospitals East Communities | Saint Louis, MO | $883.43 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.